Lumos Pharma, Inc.

NasdaqGM:LUMO Stock Report

Market Cap: US$37.5m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Lumos Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LUMO?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms730,4468.45%
Private Companies873,08110.1%
Individual Insiders1,202,36813.9%
Institutions2,088,28324.1%
General Public3,754,44043.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.3%.

Top Shareholders

Top 25 shareholders own 56.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
Stine Seed Farm, Inc.
873,081US$3.8m0%no data
8.64%
Richard Hawkins
746,854US$3.2m0%no data
8.61%
Private Advisor Group, LLC
744,513US$3.2m2,380%0.02%
8.45%
Santé Ventures, LLC
730,446US$3.2m0%no data
4.63%
Daniel Farb
400,000US$1.7m0%no data
4.19%
Goldman Sachs Group, Investment Banking and Securities Investments
362,198US$1.6m-10.9%no data
2.82%
The Vanguard Group, Inc.
244,082US$1.1m0%no data
2.47%
Renaissance Technologies LLC
213,814US$928.0k-0.93%no data
1.4%
Jefferies Financial Group Inc.,Asset Management Arm
120,651US$523.6k0%0.01%
0.88%
Greenwich Wealth Management, LLC
76,341US$331.3k0%0.02%
0.75%
Wells Fargo & Company, Securities and Brokerage Investments
64,981US$282.0k-84.3%no data
0.64%
Geode Capital Management, LLC
55,148US$239.3k8.72%no data
0.46%
BlackRock, Inc.
39,825US$172.8k-3.11%no data
0.46%
Lion Point Capital, LP
39,589US$171.8k-56.4%0.68%
0.29%
Dimensional Fund Advisors LP
25,278US$109.7k-14.6%no data
0.23%
Bridgeway Capital Management, LLC
19,643US$85.2k-28.9%no data
0.18%
Joseph S. McCracken
15,721US$68.2k0%no data
0.14%
BNY Asset Management
11,858US$51.5k0%no data
0.14%
Wealth Advisors of Iowa, LLC
11,699US$50.8k0%0.03%
0.13%
State Street Global Advisors, Inc.
11,237US$48.8k0%no data
0.13%
Two Sigma Investments, LP
11,130US$48.3k-41.3%no data
0.13%
Key Financial, Inc.
10,927US$47.4k0%0.01%
0.12%
ADAR1 Capital Management, LLC
10,000US$43.4k0%0.01%
0.11%
Thomas Raffin
9,406US$40.8k0%no data
0.1%
Lori Lawley
8,878US$38.5k8.67%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/13 11:50
End of Day Share Price 2024/12/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lumos Pharma, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertD. Boral Capital LLC.
Eun Kyung YangJefferies LLC
Elemer PirosRoth MKM